In short
Orchid Health’s embryo-genome screening via IVF to reduce risk of genetic disease, framed as creating “superbabies” by “rigging the genetic lottery” toward healthier outcomes.
Guest backgrounds
Noor Siddiqui is CEO of Orchid Health. She was a Teal Fellow (left college for grant-funded startup work), later did research at Stanford focused on IVF lab operations and disease-risk stratification models.
Key claims
Orchid is the first company to read the entire genome of a day-5 embryo, using new amplification technology to overcome tiny DNA amounts (~30 picograms). Prior methods only analyzed chromosome “chapter-level” information; Orchid claims ~100x more genomic readout. She argues genetic disease is often a “coin toss,” with millions affected and many lacking FDA-approved treatments. She says major opposition is stigma and fear of eugenics, while the most legitimate critique is cost (~$2,500 per embryo), and she supports IVF coverage.
Notable examples
Her mother’s gradual vision loss (genetic, no smoking cause) inspired her; she cites global genetic disease prevalence and infant deaths from genetic causes; first Orchid-tested baby born in 2023.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Chapters
Tap a time to open that second in VOThe Mission of Orchid Health
0:38 to 0:57
Noor Siddiqui explains Orchid's goal to help parents create healthier babies.
“Built on your live workforce data, Rippling AI can tell you what it would cost to add two more engineers this quarter, then draft the job recs and kick off the hiring workflow.”
The Mission of Orchid Health
1:09 to 1:50
Noor Siddiqui explains Orchid's goal to help parents create healthier babies.
“the stigma around reproductive technology, and how Noor deals with her skeptics, critics, and haters.”
The Genetic Lottery Explained
2:00 to 3:00
Discussion on the risks associated with natural conception and the unfairness of genetic outcomes.
“And so when people are thinking about a super baby, should they be thinking about the types of conditions or traits that we wouldn't want that would make us concerned in having a baby?”
Personal Motivation Behind Orchid
3:17 to 4:21
Noor shares her mother's experience with genetic illness and its impact on her motivations.
“Just the process of her getting a diagnosis took close to a decade.”
Accepting Genetic Risks
4:28 to 6:33
Exploration of societal acceptance of genetic risks and the need for change.
“The most consequential decision ever is like to have a child.”
Technological Advances at Orchid
6:43 to 10:06
Noor discusses the technology developed to read the entire genome of embryos.
“And we're just going to accept that that's what happens.”
Understanding the IVF Process
10:48 to 14:00
An explanation of the IVF process and how Orchid enhances its capabilities.
“For people who maybe haven't gone through the IVF process, they think they know what it is, but maybe they aren't fully up to date.”
Understanding Genetic Diseases
14:00 to 15:02
Explore how genetic diseases can be compared to simple typos in DNA.
“diseases because, again, you're only looking at 1 % or less of the DNA.”
The Quest for Information
15:16 to 16:50
Discover why the speaker values comprehensive information when it comes to reproduction.
“I just, I like to just do like the minimum to get like the maximum benefit, right?”
Teal Fellowship Experience
16:51 to 18:11
Hear about the speaker's experiences and realizations during the Teal Fellowship.
“Was there someone who was a mentor who you particularly kind of admired as sort of a successful founder in the program?”
Show all 20 chapters
Contrasting Educational Cultures
18:12 to 20:44
The difference between East Coast and West Coast educational philosophies and their impacts.
“You're speaking to a New Yorker who's just visiting San Francisco today.”
Founding Orchid: The Journey Begins
20:45 to 21:39
Learn about the inspiration that led to the founding of Orchid and its purpose.
“So was it in the back of your mind that this was the company you were going to do?”
Challenges of Launching a Startup
21:40 to 23:38
Explore the struggles and motivations behind launching a health tech company.
“One of our first investors, actually, for the company, ended up reaching out to me after seeing a tweet about a class that I was teaching.”
Navigating Criticism in Health Tech
23:39 to 27:22
Discuss the various types of criticism faced when launching a reproductive tech company.
“It's a very selfish motivation to keep trying.”
Addressing Economic Critiques
27:23 to 28:05
Examine the legitimate concerns regarding the cost and accessibility of Orchid's services.
“But your pitchforks are a little more intense.”
The Cost of IVF and Accessibility Issues
28:05 to 29:55
Discusses the economic barriers of IVF and the need for wider access.
“embryo, which is, I believe, how much it costs to study an embryo, right?”
Empowering Reproductive Choices
29:55 to 31:40
Explores the importance of making reproductive technologies available to everyone.
“And I think that the economic argument is extremely obvious, right?”
Advancements in Genetic Sequencing
31:40 to 33:39
Examines how costs in genetic sequencing are decreasing and improving access.
“and it's the most expensive it will ever be.”
Creating a New Category in Reproductive Tech
33:39 to 36:28
Highlights the innovative category of choosing between average and 'super' babies.
“Because you get to make this decision before you're pregnant.”
Future of Birth and Genetic Health
36:28 to 38:56
Looks at the evolution of reproductive choices and the impact of genetic health.
“But I would obviously want all this, like there's a whole, you know, larger stack of things that I want to see exist.”
Transcript
Automatic transcript. May contain errors.0:00Having a baby is like starting a company. Things can go wrong, often in unexpected ways. But what if things went right? What if you could guarantee that your child would win the genetic lottery? ORCID is building technology that screens embryos during IVF for hundreds of conditions, from pediatric cancers to chronic illnesses. Our guest today is ORCID's CEO, Noor Siddiqui, who calls the result super babies.
0:24Noor Siddiqui:We had to spend years actually inventing a new technology to be able to read the entire genome of an embryo, right? So we're the first company in the world to be able to read the entire genome of an embryo, which is 100 times what was available previously. Your team is at capacity and you need to fill roles fast. Don't panic. You have Rippling AI. Built on your live workforce data, Rippling AI can tell you what it would cost to add two more engineers this quarter, then draft the job recs and kick off the hiring workflow. All you have to do is ask, review, and approve. Don't settle for AI that's all talk.
0:57Head to rippling.ai slash upstarts. That's R-I-P-P-L-I-N-G dot A-I slash upstarts to sign up for exclusive access today. Today on the podcast, we're going to talk about how Orchid actually works, the stigma around reproductive technology, and how Noor deals with her skeptics, critics, and haters. She's also going to try to convince me that the West Coast is the best coast. I'm Alex Conrad, founder and editor of Upstarts Media. And this is the Upstarts Podcast, our weekly show about startup founders who punch above their weight and take on the status quo. Noor, welcome to the show.
1:35Noor Siddiqui:Thank you so much for having me. This is amazing. So we're here in San Francisco where you're based and you've been working on Orchid for a few years now. Can you tell everyone what is the mission of Orchid Health? Yeah. So at Orchid, we want to help everyone have a super baby. If you have a baby the old-fashioned way, you're basically rolling the dice and you get an average outcome. And if you come to us, you can stack the odds in your child's favor and have a super baby. And so when people are thinking about a super baby, should they be thinking about the types of conditions or traits that we wouldn't want that would make us concerned in having a baby?
2:11Or is it more about having a baby with better traits and sort of that superhero vibe that I think super baby implies, at least for me?
2:20Noor Siddiqui:Well, yeah, I think it's just something that, yeah, the media has kind of taken on. It's kind of taken a life of its own. So we've sort of more embraced it. But what it means concretely is that, unfortunately, when a embryo is created, when a human life is created, there's a lot of risk. Right. There's this idea of a genetic lottery that happens. Right. And actually, if you think about it, it's sort of like the most unfair thing that ever happens to people, right? Based on this genetic lottery, it's literally the difference between are you going to live a healthy life into your 90s or to 100, or are you going to not make it to your first birthday?
2:55Noor Siddiqui:That's literally determined by a bunch of genetic coin tosses that neither parent has any control over. I just thought that was insanely unfair. And yeah, I think that the most obvious thing, at least for me as a future parent, that I want to be able to give my child is to have their genes not work against them and hijack their entire life. Right. So I grew up watching my mom go blind. Just the process of her getting a diagnosis took close to a decade. It was like these constant specialist visits and different experts trying to find out what was wrong. And at the end of it all, it was basically, hey, there's nothing we can do.
3:35Noor Siddiqui:There's no way to reverse the vision loss. You're definitely going to go blind. You start by losing your night vision. Then she lost her peripheral vision. And then she lost her central vision as well. and like she didn't start smoking. It's not like she did something to cause that, right? It's just that there was this genetic program running silently inside of her that just took something, you know, that I think, you know, a lot of us really value away from her, right? Like a single base pair can be the difference between, you know, being able to see your grandkids' faces or not, right? If you think about my mom's story, it's actually comparatively incredibly mild to what hundreds of millions of people face, right?
4:15Noor Siddiqui:So 400 million people actually like globally have genetic diseases and, you know, 95 % of them don't even have an FDA-approved treatment, much less a cure, right? So, you know, when people are going out to do the most important thing they're ever going to do, right? The most consequential decision ever is like to have a child. I think it's actually insane that the default is that we go into that completely blind with no information, right? Like we spend more time and more energy researching, you know, where we're going to go to lunch or what stroller we get for our child. And those are extremely, you know, inconsequential, right?
4:53Noor Siddiqui:It doesn't matter at all what stroller you get or where you go to lunch, but your child's genome is fixed for life. And the consequences are literally the difference between, you know, a life with pediatric cancer or a blissfully unaware life where you're having to go to the doctor for chronic illnesses that a lot of people are facing. Sounds like your mother's experience was a powerful inspiration for you. How old were you when her condition changed? Or was this a formative experience for you at the time or something that you saw later and said, okay, this is something that is affecting me? Yeah, it actually really didn't affect me in childhood, right?
5:32Because it was actually very gradual, right?
5:35Noor Siddiqui:Like the vision loss is quite gradual. I really don't think it actually affected me until much later, right? It was really much more when I was closer to getting engaged and thinking much more concretely about a baby, not in the abstract as, oh, one day I'll have a baby, but more concretely with this specific person. And then reflecting back on the experience. Part of why I ask is because I'm curious if you already were pretty set on the path of being an entrepreneur when this started to be something that you were thinking about deeply. and it then sort of redirected or shaped which path as an entrepreneur you went on?
6:11Or if in the back of your mind, this was always a problem that maybe you would have wanted to try to solve someday?
6:18Noor Siddiqui:For me, it was really just like, this is the thing that I care about the most and that I really want to exist and that I was really disturbed is how the world worked, right? I don't know how else to describe it, but I just thought it was like, it's insanely unfair that this happened to my mom. And it's just insanely unfair that we just generally accept this idea that we're going to randomly get horrible diseases that we can't cure and we can't even really treat well. And we're just going to accept that that's what happens. And I think that when it became more concrete to me, like, hey, I'm going to be having a baby with a specific person.
6:52Noor Siddiqui:What do I think actually matters as a parent? Like, what do I actually want to do? For me, it was like the most obvious thing was I want to be able to, you know, scan my embryo for thousands of different diseases and maximize the chance that they're going to have a healthy life. Because to me, that's actually the most important parenting decision I'm ever going to make. Right. It's basically two really important parenting decisions. It's like, who's your other half? That determines that's going to shape them. And then is their life going to be hijacked by something horrible like what happened to my mom or something that, you know, you know is in your family.
7:24Noor Siddiqui:I guess it's quite selfish, but that's really what it was. It was sort of like, why is no one working on what I thought was the most important problem? And, well, if they're not going to work on it, then I have my own timelines for when I want to have kids. So I better get started. So why was no one working on the problem? Obviously, IVF has been around for a while. It's not how most of us are on the planet right now. But I guess a growing number of people are turning to IVF. Was this just not a big enough market or the technology wasn't there yet? Why was there an opportunity for ORCID to step in and advance the capabilities and possibilities here?
8:04Noor Siddiqui:Yeah. Honestly, I think it's all of the above, right? There's a massive amount of stigma around reproductive technology. Like, there's a huge cultural baggage. Like, I don't think most people realize that condoms were illegal 50 years ago, right? There's two Supreme Court cases fought over condoms, right? the first one was fought over giving married women access with the permission of their husbands and then the second was fought over giving unmarried women access right so something like extremely routine right the idea that contraceptives should exist and that people you know women should be able to choose when they get pregnant which is yeah i think a pretty broadly accepted idea today was literally illegal like not even you know in a lot of people's lifetimes, right?
8:49Noor Siddiqui:IVF was also met with intense skepticism, right? A lot of things that we take for granted, right? Like epidural, for example, right? Epidural was originally considered women were supposed to be experienced pain in childbirth, right? So there's a lot of cultural baggage around, okay, this is the way that birth should be done. And I think that that idea has seeped into genetics too, right? This idea that, oh, it should be random, like random is somehow better, right? We don't accept that in any other part of our life. Like, no other place are we like, oh, we should, you don't accept a random partner, you don't accept a random job, you don't accept, like, a random place to live.
9:25Noor Siddiqui:Like, these are all deeply considered decisions. But for some reason, the most consequential decision, right, which is, like, which child you're going to have was somehow supposed to be, is considered sacred to, like, leave it to chance. And I think that if you're on the other side of it, like, when chance goes wrong, right, and you see a child die, if you see a parent degrade beyond the point where they're kind of unrecognizable, you sort of realize that, hey, this genetic lottery really isn't so great a lot of the time, right? I think that's kind of like the taboo piece of it. And then, yeah, I think the other two are also there, right?
10:01Noor Siddiqui:So from the technology side, we had to spend years actually inventing a new technology to be able to read the entire genome of an embryo, right? So we're the first company in the world to be able to read the entire genome of an embryo, which is 100 times what was available previously, right? So we had to actually invent a new what's called amplification technology. Because when you have an embryo, you only have about 30 picograms of DNA. A picogram is a trillionth of a gram. So it's a really, really tiny quantity of DNA. So if you think about blood or saliva, you don't need amplification, right?
10:34Noor Siddiqui:You can just throw it on any type of sequencer and you can get your whole genome sequenced. But with an embryo, because you have this really tiny quantity of DNA, we actually had to invent a new method to be able to actually get that full readout on, you know, a day five old embryo. So pause right there. For people who maybe haven't gone through the IVF process, they think they know what it is, but maybe they aren't fully up to date. Yeah, yeah. What was the limiting factor? Why was the IVF process before ORCID just scratching the surface here and not going through these checks? It sounds like there was a fundamental technological problem.
11:08But was this something that people were like, you know, it would be great if we could scan for all these things, but it's not possible. And you had to rethink what was possible there or what? It was both. It was base.
11:18Noor Siddiqui:Basically, there was a unwillingness to look and there was a technological problem of how would we actually look. Just kind of backing up the way that IVF works is, you know, in your ovaries, you have a bunch of eggs. usually you ovulate one egg a month, but in every month a bunch of eggs actually die. So you actually anywhere from dozens to hundreds of eggs die every month. And what the IVF or egg freezing process does is it actually preserves those eggs. So you basically hyperstimulate your ovaries, meaning you get, just like you have follicles for hair on your head, you have follicles for eggs in your ovaries.
11:51Noor Siddiqui:So what the medication does is it synchronizes a bunch of eggs and you kind of retrieve or kind to capture a basket of eggs during a cycle, meaning one specific month. And then you can either freeze those eggs, that's egg freezing, or you can fertilize it with your partner's sperm, and then you make embryos. Those embryos grow for five days. And then on day five and six, an embryologist takes a laser. It's called a biopsy, but it's kind of like a haircut of the outer cells of the embryo. So about five cells get sent to Orchid's lab for analysis. And then the parents and their clinical team get reports.
12:27Noor Siddiqui:So they get a report on each embryo about thousands of different genetic factors, and then they get to make a decision about which embryo to transfer. And the reason that's a massive upgrade over what previously existed is you can think of the genome as like you have 3 billion letters, right? And these 3 billion letters are organized into 23 chapters, right? 23 chromosomes, you know, 23 and me. And really, because of this limitation of the analysis of that really tiny amount of DNA, you could only look at the chapter level. So what that means is like, imagine you had a proofreader for a book, and the only question they could answer for you is, does this book, you know, have 23 chapters or not?
13:08Noor Siddiqui:It couldn't actually read any of the words, can't actually do any spell check. That's kind of where the technology was stuck. And then we would just say that's feasibly the best we can do. And I guess, was that also considered acceptable because that is kind of on par with the level of info we have from a traditional reproductive process where you're sort of looking at, you know, the first sonogram and saying, or doing the first test and being like, we think your baby is going to be okay? Yeah, it's kind of similar, right? So basically in both settings, you know, chromosome analysis of embryos and what's called NIPT, so at 10 weeks of pregnancy, you can get a blood test.
13:47Noor Siddiqui:And it also can give you some genetic information about the fetus. But in both of those contexts, you're getting a really, really limited picture of the genetics of either the embryo or the baby. So you're only able to scan for a tiny number of diseases because, again, you're only looking at 1 % or less of the DNA. So really, the thing that was really important to me is I want the maximum amount of information. I don't want just the chapter level. I want to read every single letter because diseases are hiding in every single letter. Like if you think about what is a genetic disease practically, it's literally just a typo in those 3 billion letters.
14:20These days, you can chat with AI about almost any business problem. Rippling AI is built to actually solve them. That's because Rippling AI is built on your live workforce data that gives you full visibility into your startup and the ability to take action across every department. Say you're planning your next few hires. Just ask Rippling AI, what would it cost to add two more engineers this quarter? You'll instantly see a breakdown of comp ranges by level and location, so you can make the smartest hiring decision based on where your team has gaps and where the talent is. But it doesn't stop there.
14:52Rippling AI can draft the job wrecks, route them for approval, and kick off the hiring workflow. All you have to do is tap confirm and then get back to building. Don't settle for AI that's all talk. Head to rippling.ai slash upstarts and get AI that turns insights into action.
15:07Noor Siddiqui:that's r-i-p-p-l-i-n-g dot a-i slash upstarts sign up for exclusive access today are you that kind of person who wants the maximum amount of information in everything or was this something that was triggered partly because of your mom or sort of you got fired up where this specifically was the place where you're like we should always have more info yeah it's actually really funny i'm actually not um i would say information seeking in every context i think i'm more just like a, I don't know, whatever the opposite is of like Pennywise, you know, Pound Foolish, right? I just, I like to just do like the minimum to get like the maximum benefit, right?
15:42Noor Siddiqui:So I think that for whatever reason, like when it comes to like reproduction or babies, it's the opposite. Like everyone is obsessing and telling people to obsess over the wrong things, right? And to me, this is like the thing that's going to actually make the biggest difference in my child's life. So that's why I was like obsessed over it because it's sort of like whether or not I get organic food or not, it's not going to make as big of a difference as, you know, whether my child goes blind or, like, gets dementia. Like, those are going to matter a lot more. So it almost seems like this is actually, like, a massive payoff that I can get for comparatively little effort.
16:17Noor Siddiqui:But yeah, I'm not information-seeking in all contexts, actually. But you were a precocious teenager. You were a Teal Fellow, which means you agreed to to forego college and take grant funding to do a startup. But I don't believe it was this startup. It was a kind of different idea. But entrepreneurship was something that was interesting to you even back then? It's actually funny. I actually don't think it was entrepreneurship. I actually just thought school was really dumb. I barely went to high school. And I just thought it was a huge waste of time. And I was like, okay, great. This is a way to get out of college.
16:50Noor Siddiqui:But no, I don't think it was really about like, oh, I want to start a company. I think it was more just like clearly that group of people i think school i thought was really lame i was just like there's like nothing like this is extremely pointless information to like ingest and regurgitate i just hated it versus the people in the teal fellowship like i respected all of them right like they built things that i used right i was like that's cool like i like the idea of like learning from people who have made stuff that i actually use and interact with um and it has like made a dent in the universe.
17:21Was there someone who was a mentor who you particularly kind of admired as sort of a successful founder in the program?
17:28Noor Siddiqui:I actually don't even think it's about like success. I think it's the thing that really more broke my brain was the idea of like taking yourself seriously. I know that sounds really strange, but like, I think that high school, the whole enterprise is like not taking yourself seriously. It's like, okay, prepare for like in middle school, it's like prepare for high school, high school, it's like prepare for college. And it's like okay it's like this circular thing where it's like you're not you're constantly being told you're not ready and you need to like do all this stuff to be ready and i just feel like kids and students are like constantly diminished and um the west coast nantil fellowship was the total opposite it was like okay cool yeah like you should do that like it was always just like you have license to do the thing like it was that was just like insanely like mind-blowing to me right because i think the east coast not to shit on the east coast but i hate the east coast um you're You're speaking to a New Yorker who's just visiting San Francisco today.
18:18So thank you for that. Yeah.
18:19Noor Siddiqui:But yeah, I think the East Coast is like really old school. Like I feel like at least when I grew up in D.C., it was very much like, OK, so you should like study for a decade to become a lawyer or study for like a decade to become a doctor and like climb the ladder in Congress. right it was always like these like very tracked paths and then you're you don't have you're not given the voice to actually do something until like 20 years when you're like too tired to want to do anything different anyways do you know what i mean versus i think the the um ethos on the west coast is like the total opposite it's like do the thing like just do the thing and see if it fails or not and there's basically not as much yeah there's basically the tolerance for failure is just so much higher like i just met so many people who just like burned through tens of millions of dollars on what seemed like a trash idea and it was a trash idea and then it was like okay great well now i'm gonna do the other thing and then the next thing is also a trash idea great they get to put 100 million to that other trash thing and the third thing is like amazing and then that's like a you know multi-billion dollar company it's actually really funny i actually applied to the teal fellowship with this idea but i was still too um what's the word i don't know insecure scared or something to like really work on it because i was like who's gonna let a 17 year old handle their embryos and their precious cells and help them have babies.
19:37Noor Siddiqui:So yeah, I guess I waited until I was like 25 or so to start the company. And that was part of why I guess I went to Stanford was because I, you know, wanted to spend time like really deep, you know, in the research world and to really, you know, learn about all the nitty gritty details of like, what makes an IVF lab run? Like, you know, how do you actually build these models that stratify disease risk and things like that? But yeah, I think that like the real value of the experience wasn't like the mechanical things I learned, but it was more just, I don't know, like the license, basically the license to actually do the thing and to have seen it go sideways for people and be successful for people.
20:18You talk about how you could do anything you want. You go to the West Coast. Like it's maybe more iconoclastic thinking. You do go to Stanford, which is not necessarily the most rebellious, hard rock thing one could do.
20:30Noor Siddiqui:It was at the time. Basically, it was like going not going to college was like, oh, you're a rebel. And then going from the Teal Fellowship to college was like, oh, why would you do that? OK, so people are just in the order that annoyed as many people as possible. I like that. And so you got the you got the expertise basically that was going to arm you to launch Orchid. So was it in the back of your mind that this was the company you were going to do? Yeah, I've been thinking of it since I was like 16. So I've definitely been like obsessed. It's so weird. Like, I think at 16, it was much more immature.
Read the full transcript
21:00It was more just like babies.
21:02Noor Siddiqui:Right. And like, how do we make the process of having babies better? Right. How do we how do we make it so there's less uncertainty? But it wasn't like as concrete as, OK, we're going to do like an embryo screening company. So at what point did you feel that you were qualified or the world was ready for you to launch a company here and to spend the best years of your working career going for it? Oh, wow. I think that hopefully the best is yet to come. I feel like I was so naive. But you're working on it right now, so it still applies. The best will be the next few years of Orchid. So what was the plunge moment to go do it?
21:41Noor Siddiqui:One of our first investors, actually, for the company, ended up reaching out to me after seeing a tweet about a class that I was teaching. He reached out and was like, you know, when are you going to do this? Like, what are you going to, you know, when is this going to be real? And I was, I don't know, I think I'd just gotten kind of pulled into the academic world. And I was thinking about doing a PhD at the time, actually. And he was like, well, you know, don't you think you're going to have to miss your window if you wait until you graduate to actually do this? I just thought that was hilarious because obviously, you know, from doing the teal polish before, why was I, you know, still in this?
22:18You were getting told to drop out by an investor again. Yeah, exactly.
22:21Noor Siddiqui:And I was like, why is this happening again? And I don't know. I think it's weird. I think I just I had I just ended up having a lot of fun when I was at Sanford because, you know, it's just really it's a really like crazy environment where it was like totally opposite of my high school experience. were basically in high school was like nothing was ever applied or useful. And then every single class or like professor or PI that I had had done something I admired. The first baby born with orchid testing, you know, I guess giving the parents confidence was in 2023, right? And so was that the moment where you were like, we did it, this works.
22:59And like, I actually was right. Or was it more gradual? Was there a moment before that where you were like, yes?
23:05Noor Siddiqui:Oh, So, oh, I would never celebrate that early. I mean, to me, you know, we haven't succeeded until like there's way less disease in the world, right? Until like every baby born gets to be healthy, right? That's like the success state that I want to see. But yeah, no, I think that was obviously like a really insane moment for me because, you know, so many people thought what we were doing was impossible, that it would never work. And then even if it did work, no one would want to do it. But so there's lots of people constantly saying that, you know, there's always going to be a lot of naysayers.
23:37Noor Siddiqui:But it didn't really matter to me because I was sort of like, I don't care if it doesn't work because if it does work, I'm going to use it. And I really want to use it. You know what I'm saying? Because I don't know. It's a very selfish motivation to keep trying. But no, no, it was insanely cool because, again, like the whole point of this is babies, right? So being able to see that first baby born and that first, you know, family really happy was like incredibly satisfying. because all the other stuff that happens before that is like not satisfying, right? It's like a bunch of, it's a bunch of like, you know, failures over and over again to get to that.
24:11Noor Siddiqui:Oh, wow. Like this is actually something that's actually working. And not only is it working, but it's like good enough that we want to actually deploy it clinically, right? So, yeah, no, I think that was obviously like an amazing moment. But when you just think about the technological hurdles, the fundraising, the commercializing of this product, getting clinics to pick up the phone or let you visit and actually take you seriously. What was the hardest part where you were like, you know what, I'm glad we did that. I would not want to do that again. Yeah, there's a lot of haters for this, like, again, like in the reproductive tech space, people who feel really strongly about IVF, who feel really strongly about embryo screening, who feel strongly about, you know, certain diseases being screened for.
24:52Again, I think being in such like a positive environment of San Francisco and like having
24:57Noor Siddiqui:a little bit of this echo chamber of like, oh yeah, like that would obviously, um, what if things went right versus what if things went wrong? Yeah. Yeah, exactly. And not even just what if things went wrong, but basically people who are just, um, yeah, just very opposed to technology in this space. Right. Like I, that wasn't, they weren't in my ear. And then basically when you do these big, um, public launches and then there's all these like this like mob of angry people, I think I just didn't expect them to affect me at all. And then, because I was sort like, well, why would you read mean comments?
25:27Noor Siddiqui:Like, you could just stop reading them. I tell people not to read the comments, but I also read the comments. I think a lot of it was also just breaking my brain as to, like, why. I just really didn't understand, honestly, a lot of the hate. So I was like, okay, so you just want there to be more sick babies. Like, why do you want that? Like, it's just sort of like the opposing view to me was, because the status quo was just, to me, it's like clearly so much worse. um so to hear people be so activated about basically giving families more options more choice uh during the most important moment of their life was i think honestly just kind of surprising so yeah i think that was like a really big um learning for me it's basically just like hey you can't make things palatable for everyone there's always going to be people who hate what you're doing and um obviously i think the space that we're in is like particularly really divisive and explosive and people have really strong feelings about it.
26:20But it's actually
26:21Noor Siddiqui:really funny. The thing that happened to me that convinced me to sort of put this in context was really kind of the opposite. Like I was talking to just some other founders and people who were running like extremely, you know, technical companies. And there was these holy wars there too. It's like, oh my God, is there like a semi, do you want to have a semicolon or not? Right. Do you want to. Like basically just like these really arcane technical decisions that the vast majority of people don't even know anything about. And then there was just like a massive holy war over that decision and people were getting so much hate for it.
26:56Noor Siddiqui:And I was like, okay, so it actually doesn't matter whether you touch something that affects a hundred people or a million people or a billion people. There's always going to be people who feel really activated about it, even if you feel completely certain that what you're doing is... Do you get what I'm saying? So I basically realized that, okay, this is actually not a unique problem to Orchid. This is not a unique problem to reproductive tech. I get it. For any specific company, anything you do, there's always going to be people who are going to fight tooth and nail and be extremely upset about the color that you chose to launch with, the font that you chose to launch with, the most inane things.
27:36But your pitchforks are a little more intense.
27:39Noor Siddiqui:I mean, some people don't believe in IVF altogether. Some people might push back on a future where the default reproductive choice is IVF, even from ostensibly healthy couples. And some people are, of course, concerned about the idea of the designer super baby being a path towards eugenics. And also to hit you with all the greatest hits that you had to deal with. Yeah. the economic factor here of are you creating tiers of healthiness where at$2 ,500 per embryo, which is, I believe, how much it costs to study an embryo, right? So IVF is already not cheap. And so that prices out a lot of people, at least today.
28:23And so, oh, isn't ORCID only helping a elite, you know, unreachable group of people for most of us? Those would be all those critiques. yeah was it important for you to process them empathize with them and still understand you know
28:39Noor Siddiqui:why you were passionate or do you just reject them um no no it's actually the cost piece i actually think is the most legitimate criticism of all right because i think that um you know i built this company because i want everyone to have access to it it's not because i just want a tiny slice of humans have access to it um so i think that one's like very legitimate right like I think it's insane that we're living in a country where, you know, poor people don't get to have babies and rich people do, right? Because of IVF itself as an access factor, right? Like, IVF should be covered, right? Lots of other countries, they've chosen to cover IVF up to like 10 cycles in some countries, right?
29:18Noor Siddiqui:However much it takes, right? It's taken much more seriously. So I think it's really cool to see, you know, states like, you know, California covering IVF now. And hopefully every other state will follow suit. but you know unfortunately i'm not in you know control of the government and in control of insurance companies but what i think is really you know insanely cool about orchid is i think it is going to put light a fire under everyone's um seat because obviously everyone is so disgusted by this idea of well why should it be the case that some segment of society gets to have super healthy babies and everyone else gets a random outcome and we have no cures to actually reverse these diseases later.
29:56Noor Siddiqui:So I think that that is actually a really great forcing function that I hope will actually just lead to better outcomes for everyone, which is that, hey, because this is going to have lead to such massive health disparities and is such a big deal, we do need to cover it for everyone. And I think that the economic argument is extremely obvious, right? Like we already know a quarter of infants that die, die due to genetic causes. It's because they don't have a skull. They don't have a heart that's formed properly and we can't surgically fix those things. So the idea of just having those families suffer, you know, emotionally and obviously the huge, you know, cost, you know, there's an economic cost to everyone as well.
30:31Noor Siddiqui:It's just like, well, let's just avoid this whole disaster in the first place. Yeah. So in your vision for success here, is IVF the primary choice for sort of reproduction globally and it is subsidized or the costs have sufficiently decreased that is accessible to almost everyone. Would that be directionally kind of the goal? I don't think that anyone should sort of be shoving any reproductive decision around, you know, down anyone's throat, right? Like you get to choose who you marry, you get to choose when you marry, you get to choose whether you want to have kids and how many kids you want to have.
31:05Noor Siddiqui:So I definitely don't think anyone should ever be pressured to make any specific reproductive decision. But I think it should be an option that is available to everyone, right? It shouldn't be the case that, okay, just really rich people get access to it. It should be the case that everyone has access to this choice and then they get to go in, you know, to this really amazing decision and they get to choose, okay, do I want to get all this information and maximize the chance that my child's going to be healthy or do they have a different vision for their family? And no judgment either way. Obviously, I, you know, have a specific, you know, vision and decision I'm making for my own family.
31:37Noor Siddiqui:But I think that the option should be available to everyone. Yeah. In the AI world, there's talk that cost of compute, cost of using these tools will naturally go down and it's the most expensive it will ever be. Could that be the case with Orkid or is it more a policy change that would be required for it to become massively more accessible to average people? No, I think it's definitely true. Like it's really cool that like AI is making the cost of everything collapse, right? So for us specifically, there's like a couple of other separate factors that are at play, right? So one of the biggest components of cost here is sequencing, right?
32:09Noor Siddiqui:Now there's a bunch more sequencing companies and sequencing vendors, right? So there's a lot more pressure to actually reduce the cost of sequencing. You've seen it go from a billion dollars for the first genome down to only a few thousand now. And I think that that cost curve is going to continue. And then once you have the genome, well, how do you actually analyze it? That's about compute and better models. And then separately, how many diseases are you able to analyze? So we are looking at diseases like schizophrenia and bipolar and heart disease, right? But there's other diseases that people are really interested in, you know, like depression and ADHD, right?
32:44Noor Siddiqui:And the models are only going to get better and better over time as we're ingesting more and more data from more diverse populations. And we're also including more phenotypes and more input so that the experts that we, you know, employ to help build these models have more inputs to create, you know, more and more fine-grained descriptions of disease, right? Because right now, if you think about a disease, you know, you put all the experts in a room and they have, they struggle to define, you know, what is cardiovascular disease? Okay, well, do we want to define it as a heart attack? Do we want to define it as, you know, certain HGL or LDL levels, right?
33:19Noor Siddiqui:There's a lot of dispute about, okay, how do you even define a disease, right? And what does a disease look like in different people? So I think that it's really exciting that we're getting closer and closer to like, you know, the molecular basis of a lot of these diseases and what they look like in different people. And I think that it gives, it's going to end up giving parents, you know, more and more power at that earliest possible stage, right? Because you get to make this decision before you're pregnant. When you think about where you are punching above your weight the most as a startup, you know, we call it an upstart moment.
33:49An upstart moment can be kind of that moment where you just were like, as a startup, I, you know, I achieved more than people would have expected. And I'm curious why it comes to mind. Oh, I don't know.
34:02Noor Siddiqui:I think the entire company, honestly, I think we basically created an entire category. Right. There was a category that didn't exist, which is, do you want to have an average baby or do you want to have a super baby? Right. And like we created that category. And then now a ton of companies have kind of followed and are trying to build new options for parents. And I think that that's really exciting because it's actually not even just the category. I think that because of the amount of attention that there has been on this space, there's now a bunch more companies that have been funded across reproductive technology.
34:32Noor Siddiqui:And I think reproductive technology is like one of the most underfunded but highest impact spaces ever, right? Because it's funny because I'm, you know, software engineer and, you know, computer scientist and AI person by training. But the stuff that I think is the coolest is where, you know, bits meet atoms, right? Like I love self-driving cars because that actually interacts with the physical world. And I love babies because, you know, they're going to outlive us. Right. And, you know, they're literally the next generation, the next like upgraded version of humans. Right. I just think all that stuff is really cool.
35:01Noor Siddiqui:And then literally, like, reproductive technology is how are all the future humans going to be made? Right. Like, that's an insanely high impact area. Right. Fifty percent of, you know, humans have to go make more humans. So why don't we make that process better and safer for everyone involved? yet, yeah, there's just a tiny amount of talent and dollars that are going into that. So I really love that all of the noise and drama that has come out of this has also led a lot of new companies to be formed that are working on really ambitious problems. Some are a bunch of scientists who are just working on kind of these really basic science problems that are really critical, right?
35:42Noor Siddiqui:Like how do you generate eggs from stem cells? How do you help, you know, extremely premature babies survive, right? How do you make artificial wombs? How do you, you know, get more eggs with, you know, fewer fertility drugs? How do you make the entire IVF process robotic, right? Like, you know, I've been lucky enough to invest in a lot of these companies. And I think that because it's now more in the zeitgeist, which I think is in part, you know, due to our success, you know, more people are inspired to work in this space. And I think that's like, I don't know, that's like an insane, that's like even, it's even cooler than the outcome that I envisioned at first because it's sort of like, okay, I'm only working in this one lane on kind of this like one specific thing that I'm, you know, personally passionate about.
36:28Noor Siddiqui:But I would obviously want all this, like there's a whole, you know, larger stack of things that I want to see exist. And yeah, I think it's like kind of spawning an entire ecosystem. Okay. So for you, it's not an upstart moment. It's an upstart movement. That is insane. My last question for you is when you think about the time horizon to succeed or achieve the impact you want here, is this a lifetime of work? Is this something where you think in five to 10 years we see meaningful impact in terms of the volume of births you're helping with? Yeah. Making birth better is definitely a life's work.
37:02Noor Siddiqui:But I think that these trends shift a lot faster than people give them credit for. I don't know if you've seen that graph of how people meet and how people choose to get married, right? It used to be like everyone met at like church or school and now it's like that axis has crashed and now everyone's meeting through dating apps, right? And I think like, you know, 20 years ago if you said that like, hey, no one's going to meet in person, everyone's going to be matched by a computer algorithm, people would be like, that's insane. Like there's no chance that's going to happen, right? But now the majority of couples that are getting married are chosen by algorithm, right?
37:37Noor Siddiqui:That would have been insane less than 20 years ago. And I think that the same is going to be true for babies. Right now it might be edgy for me to say sex is for fun and embryo screening is for babies, but I just think it's a statement of fact. This is the most important thing that's ever going to happen in your life. Do you want to leave it to chance? Do you want to have a random outcome for your child's genome? Or do you want to maximize the chance using the best available science and technology to stack the odds toward health? Right. Because we all know that genetics has a massive role to play in everyone's health.
38:11Noor Siddiqui:And we also know that the world is getting more and more unhealthy over time. Right. Like plastics are everywhere. Pollution is everywhere. Like I want to give my kids the best possible chance. And this is this one lever that is going to have a big impact that I can push. And I think that, yeah, I just think that in the future, we're going to look back on the idea of rolling the dice as arcane and primitive in the same way that not giving women the opportunity to have, you know, condoms or epidural or a hospital birth is considered pretty insane today, right? Like those are options that every person should have.
38:44I hope Orchid is able to help your mom become a grandmother to you when you go through the finish line of the process yourself. And Nora, thanks for coming on the show.
38:55Noor Siddiqui:Thank you so much for having us. This was so fun.
From the publisher
If you could fix the genetic lottery to ensure your baby was born healthy, would you?
For entrepreneur Noor Siddiqui, there's no question. Ever since her mother started to lose her vision as the result of a genetic condition, she’s dreamed of solving the problem through better genetic testing.
And at Orchid, the startup she founded in 2019, she now offers a novel approach to genetic testing that can spot thousands of potential conditions in embryos before they’re implanted as part of the IVF process. Orchid assisted its first birth in 2023, and now works with more than 100 clinics in the U.S. and abroad.
But Siddiqui’s vision for designer “superbabies” has plenty of doubters, from Orchid’s ethical implications to its cost, at $2,500 per screened embryo. Siddiqui’s heard it all. "Right now, it might be edgy for me to say, 'Sex is for fun, and embryo screening is for babies,' but I just think it's a statement of fact.”
On the The Upstarts Podcast, Siddiqui talks about her founder journey as a Thiel Fellow turned Stanford research dropout; why she compares previous testing to proofreading only the chapter titles of a book; and how she’s gotten used to the backlash.
Plus, she talks about her Upstart Moment: sparking a new wave of reproductive tech startups that she sees carrying the field far beyond where Orchid can go alone.
CHAPTERS
00:00 Introduction
1:45 Creating ‘superbabies’
3:17 Motivated by mom’s blindness
8:04 Stigma around reproductive tech
11:26 How Orchid improves IVF
16:19 From Thiel Fellow to Stanford
21:42 Dropping out (again) for Orchid
24:40 Facing the ‘holy war’ haters
28:44 Orchid’s cost and improving access
34:00 Noor’s Upstart Moment
36:58 What success looks like
For more, visit https://www.upstartsmedia.com/
Season 2 of the Upstarts Podcast is presented by Rippling
Produced & edited by Eric Johnson from LightningPod




